Fluorouracil is not recommended for use in patients known to have certain homozygous or compound heterozygous DPYD variants that result in complete DPD deficiency. The Food and Drug Administration ...
The FDA highlights increased toxicity risks in patients with DPD deficiency when using Xeloda and 5-FU, urging genetic testing before treatment. DPD deficiency leads to severe side effects from ...
AUSTIN, Texas, Sept. 26, 2018 /PRNewswire/ -- ShipStation, the leading web-based e-commerce delivery solution, announced today that it has launched its integrated relationship with DPD, one of United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback